Now Trending: Childhood Lymphoma, CRC Screening Recommendations
Drug Topics
OCTOBER 12, 2024
Check out this recap of articles published on our sister sites during the past week.
Drug Topics
OCTOBER 12, 2024
Check out this recap of articles published on our sister sites during the past week.
Pharmacy Times
OCTOBER 12, 2024
High-resolution scans can provide a picture of a patient’s brain that typical MRIs cannot, allowing for more detailed insights into the neurological effects of COVID-19.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 12, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Pharmacy Times
OCTOBER 12, 2024
This Women Pharmacists Day, Jolynn Sessions, PharmD, BCOP, FHOPA, discussed the crucial role of women in pharmacy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Honest Apothecary
OCTOBER 12, 2024
The National Association of Specialty Pharmacy (NASP) held their annual conference at the Gaylord Opryland Hotel in Nashville, TN this year. This post is about my experience at this event, and in particular, the feeling of being small and the benefit that has. The conference ran from Sunday October 6 to Wednesday October 9, 2024. […] The post NASP, THE GAYLORD, AND FEELING SMALL appeared first on The Honest Apothecary.
Pharmacy Times
OCTOBER 12, 2024
The trial met its primary endpoint of event-free survival, furthering treatment options for resected, locally advanced head and neck squamous cell carcinoma.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
OCTOBER 12, 2024
Terry Keys highlights the role of language and terminology as barriers for patients receiving cancer care.
BioPharm
OCTOBER 12, 2024
SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product.
STAT
OCTOBER 12, 2024
Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker, but a local college student or a compassionate retiree from your neighborhood. Vice President Kamala Harris’ recently announced “Medicare at Home” plan brings us tantalizingly close to this reality.
BioPharm
OCTOBER 12, 2024
Evonik's plant-based squalene, PhytoSquene, used in parenteral drug delivery applications, won the CPHI Excellence in Pharma Award in the “Sustainability” category.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 12, 2024
Vice President Kamala Harris is in “excellent health” and “possesses the physical and mental resiliency” required to serve as president, her doctor said in a letter released Saturday that summarizes her medical history and status. Joshua Simmons, a U.S. Army colonel and physician to the vice president, wrote that Harris, 59, maintains a healthy, active lifestyle and that her most recent physical last April was “unremarkable.
STAT
OCTOBER 12, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Let's personalize your content